Kaleido Biosciences, Inc.【KLDO】 業績推移・財務諸表

(単位:千ドル) 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21
現金同等物 123,522 102,143 83,459 73,526 56,091 73,193 56,693 48,383 94,523 74,140 57,818 40,635
現金 + 有価証券 123,522 102,143 83,459 73,526 56,091 73,193 56,693 48,383 94,523 74,140 57,818 40,635
流動資産合計 123,983 101,916 83,214 73,279 57,469 77,235 62,432 48,721 95,032 74,603 58,304 42,311
有形固定資産 5,103 5,896 5,811 6,742 7,063 7,583 8,552 8,462 7,833 7,526 7,339 5,665
固定資産合計 7,285 8,081 7,998 9,027 9,350 9,744 10,713 10,623 9,994 9,687 9,500 7,826
総資産 131,268 109,997 91,212 82,306 66,819 86,979 73,145 59,344 105,026 84,290 67,804 50,137
買掛金 3,575 4,046 1,657 2,016 1,224 3,544 3,835 5,389 2,412 2,695 3,559 5,670
一年内返済予定の長期借入金 - 1,250 - - - - 1,263 2,634 4,759 3,667 6,384 16,144
流動負債合計 8,849 11,648 10,256 10,377 9,304 11,498 13,998 16,659 12,873 12,269 19,261 29,682
長期借入金 14,844 13,606 14,868 20,391 20,564 20,654 19,565 18,375 16,433 17,677 15,132 5,550
固定負債合計 15,283 13,723 14,916 23,046 23,894 24,159 23,246 22,189 20,379 21,755 19,343 9,848
総負債 24,132 25,371 25,172 33,423 33,198 35,657 37,244 38,848 33,252 34,024 38,604 39,530
資本金及び資本剰余金 233,583 235,712 239,087 241,442 245,731 282,354 290,064 294,675 368,995 371,376 373,395 375,074
利益剰余金 -126,447 -151,086 -173,047 -192,600 -212,110 -231,032 -254,163 -274,179 -297,221 -321,110 -344,195 -364,467
株主資本 107,136 84,626 66,040 48,883 33,621 51,322 35,901 20,496 71,774 50,266 29,200 10,607
有利子負債合計 14,844 14,856 14,868 20,391 20,564 20,654 20,828 21,009 21,192 21,344 21,516 21,694
純有利子負債 -108,678 -87,287 -68,591 -53,135 -35,527 -52,539 -35,865 -27,374 -73,331 -52,796 -36,302 -18,941
DEレシオ(%) 13.86 17.55 22.51 41.71 61.16 40.24 58.02 102.5 29.53 42.46 73.68 204.53